Skip to main
SLQT

SelectQuote (SLQT) Stock Forecast & Price Target

SelectQuote (SLQT) Analyst Ratings

Based on 2 analyst ratings
Hold
Strong Buy 0%
Buy 0%
Hold 100%
Sell 0%
Strong Sell 0%

Bulls say

SelectQuote Inc. demonstrates a positive outlook supported by the growth and increasing significance of its Healthcare Services segment, which is characterized by high revenue visibility and attractive economics, thus reducing overall business risk. The company's adjusted growth estimate for Medicare Advantage approved policies has been raised to 6.5% for fiscal 2026, reflecting a strong potential for increased consumer engagement and proactive workforce investments in anticipation of the Annual Enrollment Period (AEP). This strategic positioning enhances SelectQuote's ability to capture market share, reinforcing its revenue-generating capabilities across its key segments.

Bears say

SelectQuote Inc. is projected to experience a decline in approved Medicare Advantage (MA) policies by 3.9% year-over-year for FY25, largely attributed to a lower headcount within the company. The potential return of persistency headwinds could further exacerbate financial challenges, leading to negative tail-revenue and reduced cash flow from commissions. Additionally, these factors are expected to impose a significant 20% headwind on the company's adjusted EBITDA estimates, reinforcing a negative outlook on the stock.

SelectQuote (SLQT) has been analyzed by 2 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 0% recommend Buy, 100% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SelectQuote and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SelectQuote (SLQT) Forecast

Analysts have given SelectQuote (SLQT) a Hold based on their latest research and market trends.

According to 2 analysts, SelectQuote (SLQT) has a Hold consensus rating as of Feb 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $3.88, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $3.88, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SelectQuote (SLQT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.